Jaiswal Vikash, Peng Ang Song, Hanif Muhammad, Savaliya Mittal, Vadhera Ananya, Raj Nishchita, Gera Asmita, Aujla Savvy, Daneshvar Farshid, Ishak Angela, Subhan Waleed Madeeha, Hugo Aguilera-Alvarez Victor, Naz Sidra, Hameed Maha, Wajid Zarghoona
JCCR Cardiology, Varanasi, India.
Department of Cardiovascular Research, Larkin Community Hospital, South Miami, FL, USA.
Int J Cardiol Heart Vasc. 2023 Jan 11;44:101170. doi: 10.1016/j.ijcha.2023.101170. eCollection 2023 Feb.
Racial disparities have been well described in cardiovascular disease. However, the impact of race on the outcomes post - Transcatheter aortic valve replacement (TAVR) remains unknown.
We aim to evaluate the disparity among the race (black and white) post - TAVR.
We systematically searched all electronic databases from inception until September 26, 2022. The primary outcome was in-hospital all-cause mortality, and secondary outcomes was myocardial infarction (MI), acute kidney injury (AKI), permanent pacemaker implantation (PPI) or ICD, stroke, vascular complications, and major bleeding.
A total of three studies with 1,02,009 patients were included in the final analysis. The mean age of patients with white and black patients was 82.65 and 80.45 years, respectively. The likelihood of in-hospital all-cause mortality (OR, 1.01(95 %CI: 0.86-1.19), P = 0.93), stroke (OR, 0.83(95 %CI:0.61-1.13), P = 0.23, I2 = 46.57 %], major bleeding [OR, 1.05(95 %CI:0.92-1.20), P = 0.46), and vascular complications [OR, 0.92(95 %CI:0.81-1.06), P = 0.26), was comparable between white and black patients. However, patients with white race have lower odds of MI (OR, 0.65(95 %CI:0.50-0.84), P < 0.001), and AKI (OR, 0.84(95 %CI:0.74-0.95), P = 0.01) and higher odds of PPI or ICD (OR, 1.16(95 %CI: 1.06-1.27), P < 0.001, I2 = 0 %) compared with black race patients.
Our findings suggest disparity post - TAVR outcomes existed, and black patients are at higher risk of MI and AKI than white patients.• Disparity has been witnessed among patients with cardiovascular disease. However, no studies have drawn a significant association among post-TAVR patients' outcomes• Among patients who underwent TAVR, there is a difference in the adverse outcomes between black and white race patients. White patients have a lower risk of post-procedure MI and AKI compared with Black patients.• These disparities need to be addressed, and proper guidelines need to be made along with engaging patients with better medical infrastructure and treatment options..
心血管疾病中的种族差异已得到充分描述。然而,种族对经导管主动脉瓣置换术(TAVR)后结局的影响仍不清楚。
我们旨在评估TAVR后不同种族(黑人和白人)之间的差异。
我们系统检索了从数据库建立至2022年9月26日的所有电子数据库。主要结局是住院全因死亡率,次要结局是心肌梗死(MI)、急性肾损伤(AKI)、永久性起搏器植入(PPI)或植入式心脏复律除颤器(ICD)、中风、血管并发症和大出血。
最终分析共纳入三项研究,涉及102009例患者。白人和黑人患者的平均年龄分别为82.65岁和80.45岁。白人和黑人患者在住院全因死亡率(比值比[OR],1.01[95%置信区间(CI):0.86 - 1.19],P = 0.93)、中风(OR,0.83[95%CI:0.61 - 1.13],P = 0.23,I² = 46.57%)、大出血(OR,1.05[95%CI:0.92 - 1.20],P = 0.46)和血管并发症(OR,0.92[95%CI:0.81 - 1.06],P = 0.26)方面具有可比性。然而,白人患者发生MI(OR,0.65[95%CI:0.50 - 0.84],P < 0.001)和AKI(OR,0.84[95%CI:0.74 - 0.95],P = 0.01)的几率较低,而发生PPI或ICD的几率较高(OR,1.16[95%CI:1.06 - 1.27],P < 0.001,I² = 0%),与黑人患者相比。
我们的研究结果表明TAVR后结局存在差异,黑人患者发生MI和AKI的风险高于白人患者。• 心血管疾病患者中存在差异。然而,尚无研究表明TAVR术后患者结局之间存在显著关联。• 在接受TAVR的患者中,黑人和白人种族患者的不良结局存在差异。与黑人患者相比,白人患者术后发生MI和AKI的风险较低。• 这些差异需要得到解决,需要制定适当的指南,并为患者提供更好的医疗基础设施和治疗选择。